Andrew E. Singer, EVP & CFO at Epizyme, Inc. (EPZM), sold 1,013 shares at $10.36 ($10K) on 2016-07-11, disclosed to the SEC on 2016-07-13.
Scheduled sale ($10k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2017-01-10 | $24K | — | Filing → |
| EPZM | SELL | 2016-12-12 | $11K | — | Filing → |
| EPZM | SELL | 2016-11-10 | $11K | — | Filing → |